Drug Design and Discovery: Translational Biomedical Science Varies Among Countries

被引:3
作者
Weaver, Ian N. [1 ]
Weaver, Donald F. [1 ,2 ,3 ]
机构
[1] Dalhousie Univ, Dept Biomed Engn, Halifax, NS, Canada
[2] Dalhousie Univ, Dept Med Neurol, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Chem, Halifax, NS, Canada
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2013年 / 6卷 / 05期
关键词
drug discovery; drug design; BUDGET; CUTS;
D O I
10.1111/cts.12058
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Drug design and discovery is an innovation process that translates the outcomes of fundamental biomedical research into therapeutics that are ultimately made available to people with medical disorders in many countries throughout the world. To identify which nations succeed, exceed, or fail at the drug design/discovery endeavormore specifically, which countries, within the context of their national size and wealth, are pulling their weight when it comes to developing medications targeting the myriad of diseases that afflict humankindwe compiled and analyzed a comprehensive survey of all new drugs (small molecular entities and biologics) approved annually throughout the world over the 20-year period from 1991 to 2010. Based upon this analysis, we have devised prediction algorithms to ascertain which countries are successful (or not) in contributing to the worldwide need for effective new therapeutics.
引用
收藏
页码:409 / 413
页数:5
相关论文
共 19 条
[1]  
[Anonymous], WORLD POP PROSP
[2]  
[Anonymous], BMJ
[3]  
[Anonymous], NAT REV DRUG DISCOVE
[4]  
[Anonymous], 2012, WORLD EC OUTLOOK, DOI DOI 10.5089/9781616352462.081
[5]  
[Anonymous], 2011, 2011 LODG IND PROF
[6]  
[Anonymous], 2012, World Development Indicators & Global Development Finance
[7]  
[Anonymous], ANN REPORTS MED CHEM
[8]  
[Anonymous], SCI AM
[9]   The rise of micropharma [J].
Barden, Christopher J. ;
Weaver, Donald F. .
DRUG DISCOVERY TODAY, 2010, 15 (3-4) :84-87
[10]   Spain reeling from budget and staff cuts in biomedicine [J].
Catanzaro, Michele .
NATURE MEDICINE, 2012, 18 (02) :184-184